Blogs

Trump’s Top Choices for FDA Could Bolster the ‘Right-to-Try’ Movement

February 6, 2017

By DYLAN SCOTT @dylanlscott

 

WASHINGTON — Advocates of “right-to-try” laws — giving terminally ill patients wider latitude to try experimental treatments that have passed only basic safety tests — are taking another run at it. Senator Ron Johnson of Wisconsin, a Republican, has re-introduced his legislation. More than 40 of his fellow senators, including a few Democrats, have signed on.

Staffers at the Food and Drug Administration have opposed such proposals in the past. Officials there worry that “right to try” is a way of circumventing the agency’s regulatory authority. But this is now President Donald Trump’s Washington.

Continue reading at STAT News.

Stay Connected

Sign up for updates straight to your inbox.

FacebookTwitterInstagramYoutube